Abstract
Objectives To compare the sound-source localization, discrimination and tracking performance of bilateral cochlear implant users with omnidirectional (OMNI) and pinna-imitating (PI) microphone directionality modes.
Design Twelve experienced bilateral cochlear implant users participated in the study. Their audio processors were fitted with two different programs featuring either the OMNI or PI mode. Each subject performed static and dynamic sound field spatial hearing tests in the horizontal plane. The static tests consisted of an absolute sound localization test and a minimum audible angle (MAA) test, which was measured at 8 azimuth directions. Dynamic sound tracking ability was evaluated by the subject correctly indicating the direction of a moving stimulus along two circular paths around the subject.
Results PI mode led to statistically significant sound localization and discrimination improvements. For static sound localization, the greatest benefit was a reduction in the number of front-back confusions. The front-back confusion rate was reduced from 47% with OMNI mode to 35% with PI mode (p = 0.03). The ability to discriminate sound sources at the sides was only possible with PI mode. The MAA value for the sides decreased from a 75.5 to a 37.7-degree angle when PI mode was used (p < 0.001). Furthermore, a non-significant trend towards an improvement in the ability to track sound sources was observed for both trajectories tested (p = 0.34 and p = 0.27).
Conclusions Our results demonstrate that PI mode can lead to improved spatial hearing performance in bilateral cochlear implant users, mainly as a consequence of improved front-back discrimination with PI mode.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
KEK-BE, No. 2018-00901
Funding Statement
This study was in part funded by the Med-El Corporation, the Berne University Research Foundation and the Fondation Charidu.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Conflicts of Interest and Source of Funding This study was in part funded by the MED-EL Corporation, the Berne University Research Foundation and the Fondation Charidu. There are no conflicts of interest, financial, or otherwise.
Data Availability
The data referred to in this data is available as supplementary digital content.
